Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 13

Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor

Total article views   HTML views PDF downloads Totals
11,784 Dovepress* 10,892+ 473 11,365
PubMed Central* 892 237 1,129
Totals 11,784 710 12,494
*Since 18 August 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar